Methylation-associated silencing of SFRP1 in renal cell carcinoma

Yasuo Awakura1, Eijiro Nakamura, Noriyuki Ito

  • 1Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Oncology Reports
|October 25, 2008
PubMed

Insights

Secreted frizzled-related protein 1 (SFRP1) silencing by promoter hypermethylation is frequent in renal cell carcinoma (RCC). This epigenetic inactivation of SFRP1, a tumor suppressor, likely plays a key role in kidney cancer development.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Secreted frizzled-related protein 1 (SFRP1) is a tumor suppressor gene that inhibits Wnt signaling.
  • Epigenetic silencing of SFRP1 via promoter methylation is implicated in various cancers.
  • The role of SFRP1 in renal cell carcinoma (RCC) remains to be fully elucidated.

Purpose of the Study:

  • To investigate the expression and methylation status of SFRP1 in RCC.
  • To determine the association between SFRP1 promoter methylation and its expression in RCC.
  • To assess the frequency of SFRP1 alterations in RCC development.

Main Methods:

  • Analysis of SFRP1 transcript expression in RCC cell lines.
  • Bisulfite sequencing and methylation-specific PCR for SFRP1 promoter methylation analysis.
  • Quantitative real-time PCR for SFRP1 expression levels.
  • Microsatellite analysis for loss of heterozygosity at the SFRP1 locus.

Main Results:

  • SFRP1 expression was undetectable in tested RCC cell lines.
  • SFRP1 promoter hypermethylation was detected in 45.6% of conventional RCC and 25% of papillary RCC cases.
  • A significant decrease in SFRP1 expression (>3-fold) was observed in 97.1% of conventional RCC cases.
  • Loss of heterozygosity at the SFRP1 locus was infrequent (10.7% in conventional RCC).

Conclusions:

  • Methylation-associated silencing of SFRP1 is a common event in RCC.
  • SFRP1 inactivation likely contributes to kidney cancer initiation.
  • Further research is needed to understand SFRP1's role in Wnt and other signaling pathways in RCC, especially given conflicting data on beta-catenin activation.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...